|
1.
Grimm M. Prognostic value of clinicopathological parameters and outcome in
484 patients with oral squamous cell carcinoma: microvascular invasion (V+)
is an independent prognostic factor for OSCC. Clinical & translational
oncology: official publication of the Federation of Spanish Oncology
Societies and of the National Cancer Institute of Mexico. 2012;14:870-80.
http://dx.doi.org/10.1007/s12094-012-0867-2
|
|
|
|
2.
Franca DC, Monti LM, de Castro AL, Soubhia AM, Volpato LE, de Aguiar SM, et
al. Unusual presentation of oral squamous cell carcinoma in a young woman.
Sultan Qaboos Univ Med J. 2012;12:228-31.
http://dx.doi.org/10.12816/0003118
|
|
|
|
|
3.
Goepfert RP, Kezirian EJ, Wang SJ. Oral tongue squamous cell carcinoma in
young women: a matched comparison-do outcomes justify treatment intensity?.
ISRN Otolaryngol. 2014;2014:529395.
http://dx.doi.org/10.1155/2014/529395
|
|
|
|
|
4.
Eliassen AM, Hauff SJ, Tang AL, Thomas DH, McHugh JB, Walline HM, et al.
Head and neck squamous cell carcinoma in pregnant women. Head Neck.
2013;35:335-42.
http://dx.doi.org/10.1002/hed.22973
|
|
|
|
|
5.
Hirota SK, Braga FP, Penha SS, Sugaya NN, Migliari DA. Risk factors for
oral squamous cell carcinoma in young and older Brazilian patients: a
comparative analysis. Med Oral Patol Oral Cir Bucal. 2008;13:E227-31.
|
|
|
|
|
6.
Cheung EJ, Wagner H Jr, Botti JJ, Fedok F, Goldenberg D. Advanced oral
tongue cancer in a 22-year-old pregnant woman. Ann Otol Rhinol Laryngol.
2009;118:21-6.
http://dx.doi.org/10.1177/000348940911800104
|
|
|
|
|
7.
Shen S, Xu L, Yin X, Fan X, Zhang C, Hze-Khoong EP, et al. A case of a
squamous cell carcinoma of the tongue during pregnancy. Oral Oncol.
2011;47:924-6.
http://dx.doi.org/10.1016/j.oraloncology.2011.06.504
|
|
|
|
|
8.
Dumper J, Kerr P. Recurrent squamous cell carcinoma of the tongue in
pregnancy. J Otolaryngol. 2005;34:242-3.
http://dx.doi.org/10.2310/7070.2005.34406
|
|
|
|
|
9.
Lloyd CJ, Paley MD, Penfold CN, Varadarajan V, Tehan B, Gollins SW.
Microvascular free tissue transfer in the management of squamous cell
carcinoma of the tongue during pregnancy. Br J Oral Maxillofac Surg.
2003;41:109-11.
http://dx.doi.org/10.1016/S0266-4356(03)00003-2
|
|
|
|
|
10.
Cudney N, Ochs MW, Johnson J, Roccia W, Collins BM, Costello BJ. A unique
presentation of a squamous cell carcinoma in a pregnant patient.
Quintessence Int. 2010;41:581-3.
|
|
|
|
|
11.
Colella G, Izzo G, Carinci F, Campisi G, Lo Muzio L, D'Amato S, et al.
Expression of sexual hormones receptors in oral squamous cell carcinoma.
Int J Immunopathol Pharmacol. 2011;24:129-32.
|
|
|
|
|
12.
Marocchio LS, Giudice F, Correa L, Pinto Junior DS, de Sousa SO. Oestrogens
and androgen receptors in oral squamous cell carcinoma. Acta Odontol Scand.
2013;71:1513-9.
http://dx.doi.org/10.3109/00016357.2013.775335
|
|
|
|
|
13.
Nehse G, Tunn S. Androgen and progesterone receptors in oral carcinoma. J
Craniomaxillofac Surg. 1994;22:114-9.
http://dx.doi.org/10.1016/S1010-5182(05)80021-6
|
|
|
|
|
14.
Chang YL, Hsu YK, Wu TF, Huang CM, Liou LY, Chiu YW, et al. Regulation of
estrogen receptor alpha function in oral squamous cell carcinoma cells by
FAK signaling. Endocr Relat Cancer. 2014;21:555-65.
http://dx.doi.org/10.1530/ERC-14-0102
|
|
|
|
|
15.
Lukits J, Remenr E, Rs E, Ladnyi A, Ksler M, Tmr J. Molecular
identification, expression and prognostic role of estrogen- and
progesterone receptors in head and neck cancer. Int J Oncol.
2007;30:155-60.
http://dx.doi.org/10.3892/ijo.30.1.155
|
|
|
|
|
16.
Lee CC, Ho HC, Chen HL, Hsiao SH, Hwang JH, Hung SK. Squamous cell
carcinoma of the oral tongue in young patients: a matched-pair analysis.
Acta Otolaryngol. 2007;127:1214-7.
http://dx.doi.org/10.1080/00016480701230910
|
|
|
|
|
17.
Driemel O, Hertel K, Reichert TE, Kosmehl H. Current classification of
precursor lesions of oral squamous cell carcinoma principles of the WHO
classification 2005. Mund Kiefer Gesichtschir. 2006;10:89-93.
http://dx.doi.org/10.1007/s10006-006-0675-3
|
|
|
|
|
18.
Grimm M, Calger B, Teriete P, Biegner T, Munz A, Reinert S. Targeting
thiamine-dependent enzymes for metabolic therapies in oral squamous cell
carcinoma? Clin Transl Oncol. 2016;18:196-205.
http://dx.doi.org/10.1007/s12094-015-1352-5
|
|
|
|
|
19.
Grimm M, Cetindis M, Lehmann M, Biegner T, Munz A, Teriete P, et al.
Association of cancer metabolism-related proteins with oral carcinogenesis
- indications for chemoprevention and metabolic sensitizing of oral
squamous cell carcinoma? J Transl Med. 2014;12:208.
http://dx.doi.org/10.1186/1479-5876-12-208
|
|
|
|
|
20.
Diaz LK, Sneige N. Estrogen receptor analysis for breast cancer: current
issues and keys to increasing testing accuracy. Adv Anat Pathol.
2005;12:10-9.
http://dx.doi.org/10.1097/00125480-200501000-00003
|
|
|
|
|
21.
Ishida H, Wada K, Masuda T, Okura M, Kohama K, Sano Y, et al. Critical role
of estrogen receptor on anoikis and invasion of squamous cell carcinoma.
Cancer Sci. 2007;98:636-43.
http://dx.doi.org/10.1111/j.1349-7006.2007.00437.x
|
|
|
|
|
22.
Kim MJ, Lee JH, Kim YK, Myoung H, Yun PY. The role of tamoxifen in
combination with cisplatin on oral squamous cell carcinoma cell lines.
Cancer Lett. 2007;245:284-92.
http://dx.doi.org/10.1016/j.canlet.2006.01.017
|
|
|
|
|
23.
Ku TK, Crowe DL. Coactivator-mediated estrogen response in human squamous
cell carcinoma lines. J Endocrinol. 2007;193:147-55.
http://dx.doi.org/10.1677/JOE-06-0029
|
|
|
|
|
24.
Thomas C, Gustafsson JA. The different roles of ER subtypes in cancer
biology and therapy. Nat Rev Cancer. 2011;11:597-608.
http://dx.doi.org/10.1038/nrc3093
|
|
|
|
|
25.
Egloff AM, Rothstein ME, Seethala R, Siegfried JM, Grandis JR, Stabile LP.
Cross-talk between estrogen receptor and epidermal growth factor receptor
in head and neck squamous cell carcinoma. Clin Cancer Res. 2009;15:6529-40.
http://dx.doi.org/10.1158/1078-0432.CCR-09-0862
|
|
|
|
|